IST:SURGY Cash Flow Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-277.82	976.65	430.32	1,313	611.88
Depreciation & Amortization	2.19	2.19	2.19	0.65	0.05
Asset Writedown	-816.97	-816.97	-1,551	-1,511	-747.19
Change in Accounts Receivable	307.93	235.33	-492.01	116.73	-46.15
Change in Accounts Payable	-20.61	-20.61	27.9	-2.22	36.6
Change in Other Net Operating Assets	7.95	13.37	0.48	0.6	9.47
Other Operating Activities	-178.3	-1,296	951.91	43.35	42.07
Operating Cash Flow	-199.62	-703.5	-471.49	626.13	132.5
Operating Cash Flow Growth	-	-	-	372.54%	-
Acquisition of Real Estate Assets	-	-	-	-	-0.43
Sale of Real Estate Assets	47.74	231.94	361.05	32.33	23.63
Net Sale / Acq. of Real Estate Assets	47.74	231.94	361.05	32.33	23.2
Other Investing Activities	338.1	307.2	735.16	-	-
Investing Cash Flow	385.85	539.13	1,096	32.33	23.2
Short-Term Debt Issued	-	-	52.48	-	-
Total Debt Issued	-	-	52.48	-	-
Short-Term Debt Repaid	-	-52.48	-	-	-
Total Debt Repaid	-48.74	-52.48	-	-	-
Net Debt Issued (Repaid)	-48.74	-52.48	52.48	-	-
Issuance of Common Stock	4.54	4.54	-	75	45.07
Repurchase of Common Stock	-	-	-4.54	-	-
Other Financing Activities	-130.06	197.41	-1,060	313.42	-199.02
Miscellaneous Cash Flow Adjustments	-4	-16.85	-407.95	-386.92	-
Net Cash Flow	7.98	-31.75	-795.02	659.97	1.76
Levered Free Cash Flow	-338.9	301.49	-1,942	-632.56	-
Unlevered Free Cash Flow	-323.26	318.1	-1,941	-632.56	-
Change in Working Capital	1,071	430.32	-304.8	780.33	225.69